Literature DB >> 24337505

Antibiotics and Staphylococcus aureus--more than meets the MIC.

Benjamin P Howden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24337505     DOI： 10.1007/s00109-013-1113-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  12 in total

Review 1.  The co-evolution of host cationic antimicrobial peptides and microbial resistance.

Authors:  Andreas Peschel; Hans-Georg Sahl
Journal:  Nat Rev Microbiol       Date:  2006-06-12       Impact factor: 60.633

Review 2.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies.

Authors:  Robert E W Hancock; Hans-Georg Sahl
Journal:  Nat Biotechnol       Date:  2006-12       Impact factor: 54.908

Review 3.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

Authors:  Helen W Boucher; George H Talbot; John S Bradley; John E Edwards; David Gilbert; Louis B Rice; Michael Scheld; Brad Spellberg; John Bartlett
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

Review 4.  Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.

Authors:  Ashley L Hilchie; Kelli Wuerth; Robert E W Hancock
Journal:  Nat Chem Biol       Date:  2013-12       Impact factor: 15.040

5.  Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding.

Authors:  Abhay Dhand; Arnold S Bayer; Joseph Pogliano; Soo-Jin Yang; Michael Bolaris; Victor Nizet; Guiquing Wang; George Sakoulas
Journal:  Clin Infect Dis       Date:  2011-07-15       Impact factor: 9.079

6.  National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011.

Authors:  Raymund Dantes; Yi Mu; Ruth Belflower; Deborah Aragon; Ghinwa Dumyati; Lee H Harrison; Fernanda C Lessa; Ruth Lynfield; Joelle Nadle; Susan Petit; Susan M Ray; William Schaffner; John Townes; Scott Fridkin
Journal:  JAMA Intern Med       Date:  2013-11-25       Impact factor: 21.873

7.  Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.

Authors:  George Sakoulas; Cheryl Y Okumura; Wdee Thienphrapa; Joshua Olson; Poochit Nonejuie; Quang Dam; Abhay Dhand; Joseph Pogliano; Michael R Yeaman; Mary E Hensler; Arnold S Bayer; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2013-12-03       Impact factor: 4.599

Review 8.  Genomic variation and evolution of Staphylococcus aureus.

Authors:  Jodi A Lindsay
Journal:  Int J Med Microbiol       Date:  2009-10-07       Impact factor: 3.473

9.  β-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone.

Authors:  Thomas J Dilworth; Omar Ibrahim; Pamela Hall; Jora Sliwinski; Carla Walraven; Renée-Claude Mercier
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

10.  Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections.

Authors:  A Nijnik; Rew Hancock
Journal:  Emerg Health Threats J       Date:  2009-02-24
View more
  1 in total

1.  Using a sequential regimen to eliminate bacteria at sublethal antibiotic dosages.

Authors:  Ayari Fuentes-Hernandez; Jessica Plucain; Fabio Gori; Rafael Pena-Miller; Carlos Reding; Gunther Jansen; Hinrich Schulenburg; Ivana Gudelj; Robert Beardmore
Journal:  PLoS Biol       Date:  2015-04-08       Impact factor: 8.029
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.